Insights

Key Takeaways From Oregon M110 Research Symposium

Comagine Health’s Research and Evaluation Department presented findings at the Oregon Measure 110 Research Symposium in Salem alongside host RTI International, covering substance use, housing and harm reduction.

February 13, 2024

Behavioral Health

On Jan. 22, Comagine Health’s Research and Evaluation Department took the stage at the Oregon Measure 110 (M110) Research Symposium in Salem, Oregon, showcasing valuable findings alongside host RTI International. The symposium covered critical aspects of substance use, housing, harm reduction, family services and law enforcement. It featured panels on overdose mortality trends and M110 impact, substance use disorder services with M110-funded data, housing and harm reduction, and Oregon’s drug policy history with a focus on M110’s impact on arrest rates and 911 calls.

Panel 1: Overdose Mortality

Moderator: Gillian Leichtling, Senior Director of Research and Evaluation

Research indicated no direct link between Measure 110 and fatal overdoses. The surge in fatal opioid overdoses was attributed to the introduction of fentanyl into Oregon’s unregulated drug supply. Longitudinal studies found no association with Measure 110’s implementation. A 2023 study revealed that people using fentanyl were very likely to witness overdoses and administer naloxone. 

Panel 2: Substance Use Disorder Services

Moderator: Christi Hildebran, Vice President of Research and Evaluation

Comagine Health Senior Research Associate Alexis Cooke presented on the role of peers in expanding services after Measure 110. New certifications for recovery peers have increased with Measure 110 funding — 325 peers were certified in 2020, and 1,269 peers were certified in the first three quarters of 2023.

Service gaps persist despite an increase in funding for services, with challenges that include limited access to housing, withdrawal management and residential treatment services.

Panel 3: Housing, Harm Reduction and Family Services

Interviews showed that while many unstable and unhoused Oregonians sought assistance post-Measure 110, only a minority received services. Notably, few people started using drugs after the measure passed, and evidence suggested no migration to Oregon for drug use.

Panel 4: Law Enforcement

Comagine Health Senior Research Associate Danielle Good presented on data from interviews with people who use drugs about law enforcement interactions. Despite reduced drug-related arrests after Measure 110, people who use drugs, especially those who are unhoused, are still heavily policed. Survey data with people who use drugs reveal significant criminal legal engagement after Measure 110.

Funded by the Arnold Ventures Foundation, the research shed light on Measure 110’s impact, emphasizing the need for ongoing evaluation and targeted interventions to address persisting challenges in Oregon’s substance use landscape.

The recent symposium received national attention as part of an essay in the New York Times, as well as statewide coverage in Willamette Week.

Author / Contributor(s)

There are no authors to show right now.

Recent Insights

The Family Side of Substance Use and Recovery: Hope, Healing and Resources During National Recovery Month

The Medicaid Cliff: Collaboration Is Key to Protecting Medicaid Access

What Community Organizing Can Teach Us About Health System Transformation